Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance

Clinical and Vaccine Immunology

Volumn 18, Issue 6, 2011, Pages 969-977

  Karlsson, Johanna ^a,b   Andréasson, Björn ^a,b   Kondori, Nahid ^b   Erman, Evelina ^b   Riesbeck, Kristian ^c   Hogevik, Harriet ^a,d   Wennerås, Christine ^b  

^a NU Hospital Organization   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXOID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; STAPHYLOCOCCUS TOXOID; STREPTOCOCCUS ANTIGEN; TETANUS TOXOID;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MORAXELLA; MULTIPLE MYELOMA; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; TETANUS PROPHYLAXIS; VARICELLA ZOSTER VIRUS; WALDENSTROEM MACROGLOBULINEMIA;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; BACTERIAL INFECTIONS; CANDIDIASIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; TOXOPLASMOSIS; VIRUS DISEASES; WALDENSTROM MACROGLOBULINEMIA;

EID: 79957989056     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00021-11     Document Type: Article

References (37)

1. Afessa, B., and S. G. Peters. 2006. Major complications following hematopoietic stem cell transplantation. Semin. Respir. Crit. Care Med. 27:297-309.
2. Amanna, I. J., N. E. Carlson, and M. K. Slifka. 2007. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357:1903-1915.
3. Andersson, R., T. Sandberg, E. Berglin, and S. Jeansson. 1992. Cytomegalovirus infections and toxoplasmosis in heart transplant recipients in Sweden. Scand. J. Infect. Dis. 24:411-417.
4. Arvin, A. M. 1996. Varicella-zoster virus. Clin. Microbiol. Rev. 9:361-381.
5. Augustson, B. M., et al. 2005. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party. J. Clin. Oncol. 23:9219-9226.
6. Bida, J. P., et al. 2009. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin. Proc. 84:685-693.
7. Blade, J., and L. Rosinol. 2005. Renal, hematologic and infectious complications in multiple myeloma. Best Pract. Res. Clin. Haematol. 18:635-652.
8. Casadevall, A., M. Feldmesser, and L. A. Pirofski. 2002. Induced humoral immunity and vaccination against major human fungal pathogens. Curr. Opin. Microbiol. 5:386-391.
9. Chanan-Khan, A., et al. 2008. Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J. Clin. Oncol. 26:4784-4790.
10. Chapel, H. M., and M. Lee. 1994. The use of intravenous immune globulin in multiple myeloma. Clin. Exp. Immunol. 97(Suppl. 1):21-24.
11. Chee, M. S., et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
12. Espersen, F., et al. 1987. Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis. Acta Med. Scand. 222:465-470.
13. Fahey, J. L., R. Scoggins, J. P. Utz, and C. F. Szwed. 1963. Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia. Am. J. Med. 35:698-707.
14. Forghani, B., N. J. Schmidt, and J. Dennis. 1978. Antibody assays for varicella- zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J. Clin. Microbiol. 8:545-552.
15. Garcia-Sanz, R., et al. 2001. Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br. J. Haematol. 115:575-582.
16. Gaultney, J. B., R. D. Wende, and R. P. Williams. 1971. Microagglutination procedures for febrile agglutination tests. Appl. Microbiol. 22:635-640.
17. Gavazzi, G., and K. H. Krause. 2002. Ageing and infection. Lancet Infect. Dis. 2:659-666.
18. Gregersen, H., et al. 2001. Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance. Br. J. Haematol. 112:353-357.
19. Gregersen, H., et al. 1998. The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance. Eur. J. Haematol. 61:140-144.
20. Hargreaves, R. M., et al. 1995. Immunological factors and risk of infection in plateau phase myeloma. J. Clin. Pathol. 48:260-266.
21. Hata, A., et al. 2002. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N. Engl. J. Med. 347:26-34.
22. Hazlewood, M., et al. 1993. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin. Exp. Immunol. 93:157-164.
23. Jacobson, D. R., and S. Zolla-Pazner. 1986. Immunosuppression and infection in multiple myeloma. Semin. Oncol. 13:282-290.
24. Jacobsson, G., P. Colque-Navarro, E. Gustafsson, R. Andersson, and R. Mollby. 2010. Antibody responses in patients with invasive Staphylococcus aureus infections. Eur. J. Clin. Microbiol. Infect. Dis. 29:715-725.
25. Jaffe, E. S., N. L. Harris, H. Stein, and J. W. Vardiman (ed.). 2001. WHO classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues, 3rd ed. IARC Press, Lyon, France.
26. Jeansson, S., M. Forsgren, and B. Svennerholm. 1983. Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18:1160-1166.
27. Kristinsson, S. Y., et al. 2009. Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica 94:1714-1720.
28. Mandell, G. L., J. E. Bennett, and R. Dolin (ed.). 2010. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th ed. Elsevier Inc., Philadelphia, PA.
29. Nucci, M., and E. Anaissie. 2009. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin. Infect. Dis. 49:1211-1225.
30. Pilarski, L. M., et al. 1989. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Am. J. Hematol. 30:53-60.
31. Pilarski, L. M., E. J. Andrews, H. M. Serra, B. A. Ruether, and M. J. Mant. 1989. Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma. Scand. J. Immunol. 29:217-228.
32. Pratt, G., O. Goodyear, and P. Moss. 2007. Immunodeficiency and immunotherapy in multiple myeloma. Br. J. Haematol. 138:563-579.
33. Robertson, J. D., et al. 2000. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br. J. Cancer 82:1261-1265. (Pubitemid 30145342)
34. Schauer, U., et al. 2003. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin. Diagn. Lab. Immunol. 10:202-207.
35. Steer, A. C., et al. 2009. Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not. Clin. Vaccine Immunol. 16:172-175.
36. Svennerholm, B., S. Olofsson, S. Jeansson, A. Vahlne, and E. Lycke. 1984. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J. Clin. Microbiol. 19:235-239.
37. Wood, P. 2009. Primary antibody deficiency syndromes. Ann. Clin. Biochem. 46:99-108.